Abstract
Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Current Signal Transduction Therapy
Title:Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Volume: 7 Issue: 3
Author(s): Igor Afanas'ev
Affiliation:
Keywords: ROS signaling, cancer, survival, apoptosis, diabetes mellitus, N-acetylcysteine, deetherification, deprotonation, glycolysis, cytochrome-cardiolipi
Abstract: Cancer cells differ from the other cells by their ability to survive under conditions of enhanced oxidative stress. This property of cancer cells might also be an origin of resistance of tumors to drug treatment. Reactive oxygen species (ROS) overproduction (oxidative stress) might be responsible for both survival and death of cancer cells and the opposite effects of ROS signaling can depend on many reasons. In present work we consider several possible mechanisms of ROS effects on survival/death cancer cells: the different effects of two main reactive oxygen species paramagnetic free radical anion superoxide and diamagnetic molecule hydrogen peroxide, competition between protein kinases and phosphatases, and modification of ROS-depended enzyme/gene cascades. The oxidation of protein kinase B (Akt) by ROS might be of great importance for a shift of the survival to apoptotic signal in the enzymatic cascade. Dual effects of ROS overproduction on cancer cells appear to depend on the levels of oxidative stress: weak/ moderate oxidative stress enhances survival while severe oxidative stress induces cell death. The regulation of ROS overproduction by antioxidants and prooxidants is possibly an important promising way for cancer treatment.
Export Options
About this article
Cite this article as:
Afanas'ev Igor, Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment, Current Signal Transduction Therapy 2012; 7 (3) . https://dx.doi.org/10.2174/157436212802481637
DOI https://dx.doi.org/10.2174/157436212802481637 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cancer Drug Discovery Targeting Histone Methyltransferases: An Update
Current Medicinal Chemistry Ultrasound Therapeutics– A Review
Current Medical Imaging The Role of Imaging in Computer-Assisted Tumor Surgery of the Sacrum and Pelvis
Current Medical Imaging The Efficacy and Mechanism of Proteasome Inhibitors in Solid Tumor Treatment
Recent Patents on Anti-Cancer Drug Discovery The Long and Winding Road to Cancer Treatment: The Trail System
Current Pharmaceutical Design Understanding Mesenchymal Cancer: The Liposarcoma-Associated t(12;16) (q13;;p11) Chromosomal Translocation as a Model
Current Genomics Sequence and Structural Elements in the Mechanism of Function of Rhodopsin-Like Family of G Protein-Coupled-Receptors
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Irreversible LSD1 Inhibitors: Application of Tranylcypromine and Its Derivatives in Cancer Treatment
Current Topics in Medicinal Chemistry Multifunctional Proteins in Tumorigenesis: Aminoacyl-tRNA Synthetases and Translational Components
Current Proteomics State of Art and Recent Developments of Anti-Cancer Strategies Based on TRAIL
Recent Patents on Anti-Cancer Drug Discovery Targeting Telomerase for Cancer Therapy
Current Cancer Therapy Reviews NMR-based Drug Development and Improvement Against Malignant Melanoma – Implications for the MIA Protein Family
Current Medicinal Chemistry A Systematic Review of Selected Musculoskeletal Late Effects in Survivors of Childhood Cancer
Current Pediatric Reviews Evaluation of the Ability of an Organic Derivative of Ruthenium(II) to Reinforce the Cytotoxicity of Fast Neutron Against Malignant Cells in Culture
Letters in Drug Design & Discovery Regulatory Influence of Scaffolds on Cell Behavior: How Cells Decode Biomaterials
Current Pharmaceutical Biotechnology Modulation of Gene Transcription by Natural Products - A Viable Anticancer Strategy
Current Pharmaceutical Design Development of RGD-Based Radiotracers for Tumor Imaging and Therapy: Translating from Bench to Bedside
Current Molecular Medicine Monoclonal Antibody Therapies Targeting Pancreatic Ductal Adenocarcinoma
Current Drug Discovery Technologies Primary Cilia in Tumor Biology: The Primary Cilium as a Therapeutic Target in Cholangiocarcinoma
Current Drug Targets The Discovery of Antiangiogenic Molecules: A Historical Review
Current Pharmaceutical Design